Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harvest Fund Management is a premier Chinese asset management firm that serves as a major institutional investor and financier within the global life sciences and healthcare sectors. Founded in 1999 and headquartered in Beijing, the firm manages a diverse range of investment vehicles, including dedicated healthcare mutual funds and private equity portfolios. It focuses on identifying high-growth opportunities in biotechnology, innovative pharmaceuticals, medical devices, and digital health, particularly within the Chinese market. Harvest Fund Management is known for its deep research-driven approach, employing specialized teams to evaluate clinical data and market potential. The company plays a pivotal role in the biotech ecosystem by providing late-stage venture capital and supporting initial public offerings for emerging healthcare leaders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harvest Fund Management.